(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE
- Product Name
- (2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE
- CAS No.
- 439687-69-1
- Chemical Name
- (2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE
- Synonyms
- NB-415;Nelivaptan;SSR 149415;Nelivaptan(SSR-149,415);SSR 149415 - Nelivaptan;(2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide;(2S,4R)-1-((R)-5-Chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxoindolin-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide;(2S,4R)-1-[(3R)-5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-(2-methoxyphenyl)-2-oxo-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide;2-PYRROLIDINECARBOXAMIDE, 1-[(3R)-5-CHLORO-1-[(2,4-DIMETHOXYPHENYL)SULFONYL]-2,3-DIHYDRO-3-(2-METHOXYPHENYL)-2-OXO-1H-INDOL-3-YL]-4-HYDROXY-N,N-DIMETHYL-, (2S,4R)-;(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE
- CBNumber
- CB02448473
- Molecular Formula
- C30H32ClN3O8S
- Formula Weight
- 630.11
- MOL File
- 439687-69-1.mol
(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE Property
- Boiling point:
- 799.7±70.0 °C(Predicted)
- Density
- 1.414±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- 63.01mg/ml in DMSO; 63.01mg/ml in ethanol
- pka
- 14.14±0.40(Predicted)
- form
- Solid
- color
- White to off-white
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H373May cause damage to organs through prolonged or repeated exposure
- Precautionary statements
-
P260Do not breathe dust/fume/gas/mist/vapours/spray.
P314Get medical advice/attention if you feel unwell.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 6195
- Product name
- SSR149415
- Purity
- ≥98%(HPLC)
- Packaging
- 10
- Price
- $218
- Updated
- 2021/12/16
- Product number
- 6195
- Product name
- SSR149415
- Purity
- ≥98%(HPLC)
- Packaging
- 50
- Price
- $917
- Updated
- 2021/12/16
- Product number
- S684528
- Product name
- SSR149415
- Packaging
- 0.5mg
- Price
- $125
- Updated
- 2021/12/16
- Product number
- API0004743
- Product name
- (2S,4R)-1-(5-CHLORO-1-((2,4-DIMETHOXYPHENYL)SULFONYL)-3-(2-METHOXYPHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL)-4-HYDROXY-N,N-DIMETHYL-2-PYRROLIDINECARBOXAMIDE
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $320.1
- Updated
- 2021/12/16
(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE Chemical Properties,Usage,Production
Uses
SSR 149415 is a vasopressin V1b receptor antagonist.
Biological Activity
SSR149415 is an orally active, selective vasopressin V1b receptor antagonist (human/r at Ki in nM = 1.5/1.3/V1b, 91/1050/V1a, 1412/2897/V2, 174/270/OT) th at inhibits 30 nM AVP-induced Ca2+ response in human and r at V1b CHO transfectants (Ki = 1.26/2.0 nM). SSR149415 suppresses AVP-mediated physiological responses in vivo, including corticotropin secretion (1-30 mg/kg p.o. or i.p. in rats) upon exogenous AVP administration (0.3 μg/kg alone or 0.03 μg/kg with 0.1 μg corticoliberin/kg via i.v.), restraint stress-Induced corticotropin secretion (EC50 = 10 mg/kg i.p. in rats), and in a murine model of anxiety (four-plate test; 1-10 mg/kg i.p. or 3-10 mg/kg p.o. acute or 10 mg/kg/day p.o.).
in vivo
Nelivaptan (1-30 mg/kg; 30 min i.p. or 2 h p.o. before an exogenous AVP injection) inhibits exogenous AVP-induced increase in plasma corticotropin in Sprague-Dawley rats[1].
Nelivaptan (1-10 mg/kg; p.o.; 1, 2, 3, 4, and 6 h before the AVP challenge) produces powerful dose-dependent inhibition of the corticotropin increase in response to exogenous AVP plus corticotropin-releasing factor (CRF) in Sprague-Dawley rats[1].
Nelivaptan (1-10 mg/kg; i.p. 30 min or 60 min before test; or p.o. for 7 days) displays anxiolytic-like activity after acute and 7-day repeated administrations in male NMRI mice [1].
Nelivaptan (30 mg/kg; i.p.; daily for two weeks) retains efficacy in reducing both measured indices of depression-like behavior (learned helplessness and anhedonia), even when neurogenesis is blocked in male Wistar rats with chronic mild stress[2].
| Animal Model: | Male Wistar rats (300-400 g, aged 3 months) with chronic mild stress[2] |
| Dosage: | 30 mg/kg |
| Administration: | Intraperitoneal injection (i.p.); daily for two weeks |
| Result: | Chronic administration reversed learned helplessness and anhedonia even when methylazoxymethanol (MAM) was administered. Attenuated these depressive-like behaviors after 1 week. Restored the density of Ki-67-positive cells to control levels. |
| Animal Model: | Male Sprague-Dawley CD rats (275-300 g)[1] |
| Dosage: | 1, 3, 10, 30 mg/kg |
| Administration: | Intraperitoneal injection (i.p.) or Oral gavage (p.o.); 30 min i.p. or 2 h p.o. before an exogenous AVP injection |
| Result: | Antagonized AVP-induced corticotropin secretion in a dose-dependent manner by both intraperitoneal and oral routes. The inhibition was significant from 10 mg/kg p.o. and 3 mg/kg i.p. upwards. The inhibitory action lasted significantly for more than 2 h at 10 mg/kg i.p. and up to 4 h at 10 mg/kg p.o.. Had no effect on basal corticotropin plasma levels up to 30 mg/kg p.o.. |
| Animal Model: | Male Sprague-Dawley CD rats (275-300 g)[1] |
| Dosage: | 1, 3, 10 mg/kg |
| Administration: | Oral gavage (p.o.); 1, 2, 3, 4, and 6 h before the AVP challenge (10 mg/kg) |
| Result: | Produced powerful dose-dependent inhibition of the corticotropin increase in response to exogenous AVP plus corticoliberin; the effect was significant from the dose of 3 mg/kg p.o.. Complete blockade was achieved at 10 mg/kg. Showed a fast onset of action, the inhibitory effect was maximal at 1 h after administration. The inhibitory effect on corticotropin secretion lasted significantly more than 4 h, demonstrating a long-lasting oral effect in a specific V1b-related model. |
| Animal Model: | Male NMRI mice (20 g)[1] |
| Dosage: | 1, 3, 10 mg/kg |
| Administration: | Intraperitoneal injection (i.p.) or Oral gavage (p.o.); i.p. (1, 3, 10 mg/kg) 30 min or 60 min befeore; p.o. (10 mg/kg) for 7 days, |
| Result: | In the acute experiments, i.p. and p.o. compound increased the number of punished crossings showing marked anxiolytic effects. Post hoc analysis revealed that these effects reached statistical significance from 3 mg/kg p.o. and i.p. The anxiolytic-like activity was still significantly maintained when given repeatedly at 10 mg/kg p.o. for 7 days. The oral time course of the anxiolytic-like action performed at 10 mg/kg indicated that effects lasted for more than 4 h. |
storage
Store at -20°C
(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE Preparation Products And Raw materials
Raw materials
Preparation Products
(2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE Suppliers
- Tel
- 400-164-7117 13681763483
- Fax
- +86-21-61629029
- product02@bidepharm.com
- Country
- China
- ProdList
- 39966
- Advantage
- 60
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 400-9205774
- sales@glpbio.cn
- Country
- China
- ProdList
- 6777
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- 13989459766
- 348632238@qq.com
- Country
- China
- ProdList
- 177
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- 1173954148q
- meishipharma@126.com
- Country
- China
- ProdList
- 20033
- Advantage
- 58
- Tel
- 571-13989459766 18112526015
- sales@runyanpharma.com
- Country
- China
- ProdList
- 471
- Advantage
- 58
- Tel
- 18024082417
- market@ubiochem.com
- Country
- China
- ProdList
- 9835
- Advantage
- 58
- Tel
- 18003437475
- Fax
- 1-612-656-4400
- rdname@qq.com
- Country
- China
- ProdList
- 6960
- Advantage
- 58
View Lastest Price from (2S,4R)-1-[(R)-5-CHLORO-1-(2,4-DIMETHOXY-BENZENESULFONYL)-3-(2-METHOXY-PHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL]-4-HYDROXY-PYRROLIDINE-2-CARBOXYLIC ACID DIMETHYLAMIDE manufacturers
- Product
- Nelivaptan(SSR-149415) 439687-69-1
- Price
- US $0.00-0.00/g
- Min. Order
- 1g
- Purity
- 99.0%min. HPLC
- Supply Ability
- 10000
- Release date
- 2024-09-19